Prospective memory and apolipoprotein E in healthy aging and early stage Alzheimer's disease

Neuropsychology

Volumn 20, Issue 6, 2006, Pages 633-644

  Duchek, Janet M ^a   Balota, David A ^a   Cortese, Michael ^b,c  

^a WASHINGTON UNIVERSITY   (United States)

^b School of Business   (United States)

^c UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

Aging; Allele; Alzheimer's disease; Apolipoprotein E; Early stage; Prospective memory

Indexed keywords

APOLIPOPROTEIN E4;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; HUMAN; HUMAN EXPERIMENT; LEARNING; MEMORY; MEMORY DISORDER; PREDICTION; PRIORITY JOURNAL; RISK; TASK PERFORMANCE; WORD LIST RECALL;

ADOLESCENT; ADULT; AGED; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; FEMALE; GENOTYPE; HUMANS; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; RISK ASSESSMENT;

EID: 33750993076     PISSN: 08944105     EISSN: None     Source Type: Journal    
DOI: 10.1037/0894-4105.20.6.633     Document Type: Article

References (79)

1. Armitage, S. G. (1946). An analysis of certain psychological tests used in evaluation of brain injury. Psychological Monographs, 60, 1-48.
2. Balota, D. A., & Faust, M. E. (2001). Attention in dementia of the Alzheimer's type. In F. Boller & S. F. Cappa (Eds.), Handbook of neuropsychology (2nd ed., pp. 51-80.) New York: Elsevier Science.
3. Benton, A. L. (1963). The revised Visual Retention Test: Clinical and experimental applications. San Antonio, TX: Psychological Corporation.
4. Berg, L. (1988). Clinical Dementia Rating (CDR). Psychopharmacology Bulletin, 24, 637-639.
5. Berg, L., McKeel, D. W., Miller, P. J., Storandt, M., Rubin, E. H., Morris, J. C., et al. (1998). Clinicopathologic studies in cognitively healthy aging and Alzheimer disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Archives of Neurology, 55, 326-335.
6. Blacker, D., Haines, J. L., Rodes, L., Terwedow, H., Go, R. C., Harell, L. E., et al. (1997). APOE-4 and age at onset of Alzheimer's disease: The NIMH Genetics Initiative. Neurology, 48, 139-147.
7. Bondi, M. W., Salmon, D. P., Galasko, D., Thomas, R. G., & Thal, L. J. (1999). Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychology and Aging, 14, 295-303.
8. Breitner, J. C. S., Wyse, B. W., Anthony, J. C., Welsh-Bohmer, K. A., Steffens, D. C., Norton, M. C., et al. (1999). APOE-ε4 count predicts age when prevalence of AD increases, then declines: The Cache County Study. Neurology, 53, 321-331.
9. Burgess, P. W., Quayle, A., & Frith, C. D. (2001). Brain regions involved in prospective memory as determined by positron emission tomography. Neuropsychologia, 39, 545-555.
10. Burgess, P. W., & Shallice, T. (1997). The relationship between prospective and retrospective memory: Neuropsychological evidence. In M. A. Conway (Ed.), Cognitive models of memory (pp. 247-272). Cambridge, MA: MIT Press.
11. Carr, D. B., Gray, S., Baty, J., & Morris, J. C. (2000). The value of informant vs. individual's complaints of memory impairment in early dementia. Neurology, 55, 1724-1726.
12. Caselli, R. J., Graff-Radford, N. R., Reiman, E. M., Weaver, A., Osborne, D., Lucas, J., et al. (1999). Preclinical memory decline in cognitively normal apolipoprotein E-e4 homozygotes. Neurology, 53, 201-207.
13. Caselli, R. J., Reiman, E. M., Osborne, D., Hentz, J. G., Baxter, L. C., Hernandez, J. L., et al. (2004). Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology, 62, 1990-1995.
14. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993, 13 August). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
15. Dempster, F. N. (1992). The rise and fall of the inhibitory mechanism: Toward a unified theory of cognitive development and aging. Developmental Review, 12, 45-75.
16. Driscoll, I., McDaniel, M. A., & Guynn, M. J. (2005). Apolipoprotein E and prospective memory in normally aging adults. Neuropsychology, 19, 28-34.
17. Einstein, G. O., & McDaniel, M. A. (1990). Normal aging and prospective memory. Journal of Experimental Psychology: Learning, Memory, and Cognition, 16, 717-726.
18. Einstein, G. O., & McDaniel, M. A. (1996). Retrieval processes in prospective memory: Theoretical approaches and some new empirical findings. In M. Brandimonte, G. O. Einstein, & M. A. McDaniel (Eds.), Prospective memory: Theory and applications (pp. 115-141). Mahwah, NJ: Erlbaum.
19. Einstein, G. O., McDaniel, M. A., Richardson, S. L., Guynn, M. J., & Cunfer, A. R. (1995). Aging and prospective memory: Examining the influences of self-initiated retrieval processes. Journal of Experimental Psychology: Learning, Memory, and Cognition, 21, 996-1007.
20. Engle, R. W., Kane, M. J., & Tuholski, S. W. (1999). Individual differences in working memory capacity and what they tell us about controlled attention, general fluid intelligence, and functions of the prefrontal cortex. In A. Miyake & P. Shah (Eds.), Models of working memory: Mechanisms of active maintenance and executive control (pp. 102-134). New York: Cambridge University Press.
21. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B. T., Kukull, W. A., Mayeux, R., et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. JAMA, 278, 1349-1356.
22. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-Mental State: A practical method for grading the state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
23. Glisky, E. L. (1996). Prospective memory and the frontal lobes. In M. Brandimonte, G. O. Einstein, & M. A. McDaniel (Eds.), Prospective memory: Theory and applications (pp. 249-266). Mahwah, NJ: Erlbaum.
24. Goodglass, H. & Kaplan, E. (1983a). Boston Diagnostic Aphasia Examination Booklet: III. Oral expression, J. Animal naming (fluency in controlled association). Philadelphia: Lea & Febiger.
25. Goodglass, H., & Kaplan, E. (1983b). Boston Naming Test. Philadelphia: Lea & Febiger.
26. Greenwood, P. M., Lambert, C., Sunderland, T., & Parasuraman, R. (2005). Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: Results from the National Institute of Mental Health's BIOCARD study. Neuropsychology, 19, 199-211.
27. Greenwood, P. M., Sunderland, T., Friz, J. L., & Parasuraman, R. (2000). Genetics and visual attention: Selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene. Proceedings of the National Academy of Sciences of the United States of America, 97, 11661-11666.
28. Grober, E. & Sliwinski, M. (1991). Development and validation of a model for estimating premorbid verbal intelligence in the elderly. Journal of Clinical and Experimental Neuropsychology, 13, 933-949.
29. Guynn, M. J., McDaniel, M. A., & Einstein, G. O. (2001). Remembering to perform actions: A different type of memory? In H. D. Zimmer, R. L. Cohen, M. J. Guynn, J. Engelkamp, R. Kormi-Nouri, & M. A. Foley (Eds.), Memory for action: A distinct form of episodic memory? (pp. 25-48). Oxford, England: Oxford University Press.
30. Henderson, A. S., Easteal, S., Jorm, A. F., Mackinnon, A. J., Korten, A. E., Christensen, H., et al. (1995). Apolipoprotein-E allele epsilon-4, dementia, and cognitive decline in a population sample. Lancet, 346, 1387-1390.
31. Henry, J. D., MacLeod, M. S., Phillips, L. H., & Crawford, J. R. (2004). A meta-analytic review of prospective memory and aging. Psychology and Aging, 19, 27-39.
32. Hughes, C. P., Berg, L., Danzinger, W., Coben, L. A., & Martin, R. L. (1982). A new clinical scale for the staging of dementia. British Journal of Psychiatry, 140, 566-572.
33. Huppert, F. A., & Beardsall, L. (1993). Prospective memory impairment as an early indicator of dementia. Journal of Clinical and Experimental Neuropsychology, 15, 805-821.
34. Huppert, F. A., Johnson, T., & Nickson, J. (2000). High prevalence of prospective memory impairment in the elderly and in early-stage dementia: Findings from a population-based study. Applied Cognitive Psychology, 14, S63-S81.
35. Kanne, S. M., Balota, D. A., Storandt, M., McKeel, D. W., & Morris, J. C. (1998). Relating anatomy to function in Alzheimer's disease. Neurology, 50, 979-985.
36. Kim, K. W., Youn, J. C., Jhoo, J. H., Lee, D. Y., Lee, K. U., Lee, J. H., et al. (2002). Apolipoprotein E epsilon 4 allele is not associated with the cognitive impairment in community-dwelling normal elderly individuals. International Journal of Geriatric Psychiatry, 17, 635-640.
37. Maylor, E. A. (1995). Prospective memory in normal ageing and dementia. Neurocase, 1, 285-289.
38. Maylor, E. A., Smith, G., Della Sala, S., & Logie, R. H. (2002). Prospective and retrospective memory in normal aging and dementia: An experimental study. Memory & Cognition, 30, 871-884.
39. McDaniel, M. A., & Einstein, G. O. (2000). Strategic and automatic processes in prospective memory retrieval: A multiprocess framework. Applied Cognitive Psychology, 14, S127-S144.
40. McDaniel, M. A., Glisky, E. L., Rubin, S. R., Guynn, M. J., & Routhieaux, B. C. (1999). Prospective memory: A neuropsychological study. Neuropsychology, 13, 103-110.
41. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 934-939.
42. Morris, J. C. (1993). The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43, 2412-2414.
43. Morris, J. C. (2003). Dementia update 2003. Alzheimer's Disease and Associated Disorders, 17, 245-258.
44. Morris, J. C. (2006). Mild cognitive impairment is early-stage Alzheimer disease. Archives of Neurology, 63, 15-16.
45. Morris, J. C., Price, J. L., McKeel, D. W., Higdon, R., Buckles, V. D., & NNA Study Group. (2004). The neurobiology of nondemented aging. Neurobiology of Aging, 25(Suppl. 2), 137.
46. Morris, J. C., Storandt, M., McKeel, D. W., Jr., Rubin, E. H., Price, J. L., Grant, E. A., & Berg, L. (1996). Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology, 46, 707-719.
47. Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L. Rubin, E. H., & Berg, L. (2001). Mild cognitive impairment represents early-stage Alzheimer disease, Archives of Neurology, 58, 397-405.
48. Moscovitch, M., & Winocur, G. (1992). The neuropsychology of memory and aging. In F. I. M. Craik & T. A. Salthouse (Eds.), The handbook of aging and cognition (pp. 315-372). Hillsdale, NJ: Erlbaum.
49. O'Hara, R., Yesavage, J. A., Kraemer, H. C., Mauricio, M., Friedman, L. F., & Murphy, G. M., Jr. (1998). The APOE epsilon 4 allele is associated with decline on delayed recall performance in community-dwelling older adults. Journal of the American Geriatric Society, 46, 1493-1498.
50. Park, D. C., Hertzog, C., Kidder, D. P., Morrell, R. W., & Mayhorn, C. B. (1997). Effect of aging on event-based and time-based prospective memory. Psychology and Aging, 12, 314-327.
51. Payami, H., Grimslid, H., Oken, B., Camicioli, R., Sexton, G., Dame, A., et al. (1997). A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): Effects of family history and apolipoprotein E genotype. American Journal of Human Genetics, 60, 948-956.
52. Perry, R. J., & Hodges, J. R. (1999). Attention and executive deficits in Alzheimer's disease: A critical review. Brain, 122, 383-404.
53. Petrides, M., & Milner, B. (1982). Deficits on subject-ordered tasks after frontal-and temporal-lobe lesions in man. Neuropsychologia, 20, 249-262.
54. Price, J. L., & Morris, J. C. (1999). Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Annals of Neurology, 45, 358-368.
55. Raz, N., Gunning-Dixon, F. M., Head, D., Dupuis, J. H., McQuain, J., Briggs, S. D., et al. (1997). Selective aging of the human cerebral cortex observed in vivo: Differential vulnerability of the prefrontal gray matter. Cerebral Cortex, 7, 268-282.
56. Riley, K. P., Snowdon, D. A., Saunders, A. M., Roses, A. D., Mortimer, J. A., & Nanyakkara, N. (2000). Cognitive function and apolipoprotein E in very old adults: Findings from the Nun Study. Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 55, S69-S75.
57. Rosen, V. M., Bergeson, J. L., Putman, K., Harwell, A., & Sunderland, T. (2002). Working memory and apolipoprotein E: What's the connection? Neuropsychologia, 40, 2226-2233.
58. Rosen, V. M., Sunderland, T., Levy, J., Harwell, A., McGee, L., Hammond, C., et al. (2004). Apolipoprotein E and category fluency: Evidence for reduced semantic access in healthy normal controls at risk for developing Alzheimer's disease. Neuropsychologia, 43, 647-658.
59. Rubin, E. H., Storandt, M., Miller, J. P., Kinscherf, D. A., Grant, E. A., Morris, J. C., & Berg, L. (1998). A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Archives of Neurology, 55, 395-401.
60. Salthouse, T. A., Berish, D. E., & Siedlecki, K. L. (2004). Construct validity and age sensitivity of prospective memory. Memory & Cognition, 32, 1133-1148.
61. Shimamura, A. P., & Jurica, P. J. (1994). Memory interference effects and aging: Findings from a test of frontal lobe function. Neuropsychology, 8, 408-412.
62. Sliwinski, M. J., Hofer, S. M., Hall, C., Buschke, H., & Lipton, R. B. (2003). Modeling memory decline in older adults: The importance of preclinical dementia, attrition, and chronological age. Psychology and Aging, 18, 658-671.
63. Sliwinski, M. J., Lipton, R. B., Buschke, H., & Stewart, W. F. (1996). The effect of preclinical dementia on estimates of normal cognitive function in aging. Journal of Gerontology: Psychological Sciences, 51B, P217-P225.
64. Small, B. J., Basun, H., & Backman, L. (1998). Three years change in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia. Psychology and Aging, 13, 80-87.
65. Small, B. J., Graves, A. B., McEvoy, C. L., Crawford, F. C., Mullan, M., & Mortimer, J. A. (2000). Is APOE-e-4 a risk factor for cognitive impairment in normal aging? Neurology, 54, 2082-2088.
66. Small, B. J., Rosnick, C. B., Fratiglioni, L., & Backman, L. (2004). Apolipoprotein E and cognitive performance: A meta-analysis. Psychology and Aging, 19, 592-600.
67. Smith, G. E., Bohac, D. L., Waring, S. C., Kokmen, E., Tangalos, E. G., Invik, R. J., et al. (1998). Apolipoprotein E genotype influences cognitive "phenotype" in patients with Alzheimer's disease but not in healthy control subjects. Neurology, 50, 355-362.
68. Storandt, M., Grant, E. A., Miller, J. P., & Morris, J. C. (2002). Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology, 59, 1034-1041.
69. Storandt, M., Grant, E. A., Miller, J. P., & Morris, J. C. (in press). Longitudinal course and neuropathological outcomes in original vs. revised MCI and PreMCI. Neurology.
70. Storandt, M., & Hill, R. D. (1989). Very mild senile dementia of the Alzheimer type. II. Psychometric test performance. Archives of Neurology, 46, 383-386.
71. Teng, E. L., & Chui, H. C. (1987). The modified Mini-Mental State (3MS) Examination. Journal of Clinical Psychiatry, 48, 314-318.
72. Thurstone, L.L., & Thurstone, L.G. (1949). Examiner manual for the SRA Primary Mental Abilities Test. Chicago: Science Research Associates.
73. Wechsler, D. (1955). Wechsler Adult Intelligence Scale [Manual]. San Antonio, TX: Psychological Corporation.
74. Wechsler, D., & Stone, C. P. (1973). Wechsler Memory Scale [Manual]. San Antonio, TX: Psychological Corp.
75. West, R. (2005). The neural basis of age-related declines in prospective memory. In R. Cabeza, L. Nyberg, & D. Park (Eds.), Cognitive neuroscience of aging: Linking cognitive and cerebral aging (pp. 246-264). London: University Press.
76. West, R. L. (1996). An application of prefrontal cortex function theory to cognitive aging. Psychological Bulletin, 120, 272-292.
77. Wilson, R. S., Schneider, J. A., Barnes, L. L., Beckett, L. A., Aggarwal, N. T., Cochran, E. J., et al. (2002). The apolipoprotein E e4 allele and decline in different cognitive systems during a 6-year period. Archives of Neurology, 59, 1154-1160.
78. Wolf-Klein, G. P., Silverstone, F. A., Levy, A. P., & Brod, M. S. (1989). Screening for Alzheimer's disease by clock drawing. Journal of the American Geriatric Society, 37, 730-736.
79. Yaffe, K., Cauley, J., Sands, L., & Browner, W. (1997). Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Archives of Neurology, 54, 1110-1114.